A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
Authors
Laura Saunders,
Alexander BankovichWade Anderson,
Monette Aujay,
Sheila Bheddah,
KristenAnn Black,
Radhika Desai,
Paul Escarpe,
Johannes Hampl,
Amy Laysang,
David Liu,
Javier Lopez-Molina,
Milly Milton,
Albert Park,
Marybeth Pysz,
Hui Shao,
Brian Slingerland,
Michael Torgov,
Samuel Williams,
Orit Foord,
Philip Howard,
Jacek Jassem,
A. Badzio,
Piotr Czapiewski,
David Harpole,
Afshin Dowlati,
Pierre Massion,
William Travis,
M. Pietanza,
John Poirier,
Charles Rudin,
Robert Stull +30 authors
,
Scott Dylla Tip Tip